Antimicrobial resistance (AMR) could cause an estimated 39 million deaths over the next 25 years, threatening the future of modern medicine, the World Health Organization (WHO) has warned.
The growing resistance of bacteria and other microorganisms to medicines is making infections increasingly difficult to treat. Health experts caution that routine medical procedures, including surgery and childbirth could become more dangerous if effective treatments continue to lose their ability to fight infections.
Speaking at the sixth Annual Global Media Forum on AMR on November 16, WHO officials said progress in preventing infections, improving diagnosis and ensuring the responsible use of antibiotics remains too slow to meet international targets.
Jean-Pierre Nyemazi acting director of the WHO’s AMR department, described antimicrobial resistance as a widespread threat to modern healthcare. He warned that drug resistant infections have been claiming lives for years without receiving the attention they deserve.
Millions of Deaths Already Linked to Drug Resistance
WHO figures indicate that antimicrobial resistance was directly responsible for more than one million deaths in 2021 and associated with approximately 4.7 million additional deaths.
The latest global surveillance data also highlight the growing scale of the problem. In 2023, one in every six laboratory confirmed bacterial infections reported to the WHO was resistant to the antibiotics used to treat it.
Experts warn that without effective medicines, common infections could become harder to control, increasing the risks associated with hospital treatment and routine healthcare.
National Action Plans Still Lack Funding
A WHO assessment covering 183 countries found that nearly nine out of 10 had developed national action plans to tackle antimicrobial resistance. This marks a significant increase from 2017, when only around four in 10 countries had such plans.
However, implementation remains a major challenge. Only 42 countries, representing fewer than one in five, had plans that were adequately financed, implemented and monitored.
Pravasha Prakash an AMR technical officer at the WHO, said countries were making progress but needed to accelerate their efforts to achieve global targets by 2030.
WHO Introduces New Diagnostic Tools
The WHO has announced two new tools to help countries improve the detection and monitoring of drug resistant infections.
The first outlines the essential diagnostic tests that should be available at every level of healthcare, from primary care centres to referral hospitals.
The second provides a collection of 73 laboratory procedures covering the entire diagnostic process, including sample collection, pathogen identification and antibiotic susceptibility testing.
WHO surveillance head Sylvia Bertagnolo stressed that testing is essential for effective treatment. Without proper diagnosis, healthcare professionals may have to prescribe medicines without knowing the exact cause of an infection or which antibiotic is likely to work.
Prevention and Responsible Medicine Use Are Essential
The WHO says tackling antimicrobial resistance requires a combination of prevention, improved healthcare access and responsible use of medicines.
Key measures include strengthening infection prevention and control, expanding vaccination, improving access to clean water and sanitation, and ensuring that antibiotics and other antimicrobial medicines are used appropriately.
Experts warn that coordinated action by governments, healthcare systems, laboratories and communities is essential to slow the spread of resistance.
Without faster progress, antimicrobial resistance could undermine decades of medical advances and make infections that are currently treatable increasingly dangerous worldwide.
